| Product Code: ETC9927701 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multiple sclerosis in the UAE |
4.2.2 Growing awareness about multiple sclerosis and its treatment options |
4.2.3 Advancements in drug development and treatment options for multiple sclerosis |
4.3 Market Restraints |
4.3.1 High cost of multiple sclerosis drugs |
4.3.2 Limited access to specialized healthcare facilities for multiple sclerosis treatment |
4.3.3 Stringent regulations and approval processes for new drugs in the UAE |
5 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Trends |
6 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market, By Types |
6.1 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Interferon Beta, 2021- 2031F |
6.1.4 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Mixed Polymers, 2021- 2031F |
6.1.5 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By NF-kB Inhibitor, 2021- 2031F |
6.1.6 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.7 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Relapsng-remitting MS (RRMS), 2021- 2031F |
6.2.3 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Primar-progressive MS (PPMS), 2021- 2031F |
6.2.4 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Secondary-progressive MS (SPMS), 2021- 2031F |
6.2.5 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Progressive-relapsng MS (PRMS), 2021- 2031F |
6.3 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Prenteral, 2021- 2031F |
6.3.3 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Retail Pharmacies & Drug Stores, 2021- 2031F |
6.4.4 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Imports from Major Countries |
8 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Key Performance Indicators |
8.1 Number of patients diagnosed with multiple sclerosis in the UAE |
8.2 Rate of adoption of innovative multiple sclerosis drugs in the market |
8.3 Investment in research and development for multiple sclerosis treatments |
8.4 Patient satisfaction and adherence to prescribed multiple sclerosis drug therapy |
8.5 Number of healthcare professionals trained in multiple sclerosis diagnosis and treatment in the UAE |
9 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Multiple Sclerosis Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |